Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of Reconciliations of Basic and Diluted Net Loss Per Share

The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted net loss per share of common stock attributable to NantHealth for the three months ended March 31, 2023 and 2022:


	Three Months Ended March 31,
	2023		2022
	Common Stock		Common Stock
Net income (loss) per share numerator:




Net income (loss) for basic and diluted net loss per share	$	(12,241)	$	(15,950)
Weighted-average shares for basic and diluted net loss per share	7,703,304		7,701,416



Basic and diluted net income (loss) per share:


Total net income (loss) per share - common stock	$	(1.59)	$	(2.07)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following number of potential common shares at the end of each period were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive for the periods presented:


	March 31,
	2023	2022


Unvested and vested and unissued restricted stock units	3,990	7,980
Unexercised stock options	875,158	954,125
Convertible notes	2,382,190	2,382,190